Sandbox:DAMI: Difference between revisions
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
==Gynecomastia== | ==Gynecomastia risk factors== | ||
===Risk factors=== | ===Risk factors=== | ||
: The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial. | |||
====Common Risk Factors==== | ====Common Risk Factors==== | ||
* Idiopathic | * Idiopathic | ||
| Line 39: | Line 40: | ||
== Physical Examination == | == Physical Examination == | ||
== Pathophysiolohy == | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:28, 18 May 2017
Gynecomastia risk factors
Risk factors
- The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.
Common Risk Factors
- Idiopathic
- Drugs (12765)
- Cirrhosis
- Starvation and Refeeding
- Male hypogonadism
- Testicular neoplasms
- Hyperthyroidism
- Chronic Kidney disease
- Tumors
Less Common Risk Factors
- Feminizing adrenal tumors
- Ectopic hCG
- Disorders of sex development
- Familial prepubertal gynecomastia
Causes
History and Symptoms
Physical Examination
Pathophysiolohy
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.